Alicaforsen
ISIS 2302-CS21
Phase 3 small_molecule completed
Quick answer
Alicaforsen for Crohn's Disease is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Crohn's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed